NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

代謝性疾病用藥的全球市場(∼2021年):COVID-19影響與2030年前的復甦

Metabolic Disorders Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030

出版商 The Business Research Company 商品編碼 990344
出版日期 按訂單生產 內容資訊 英文 300 Pages
商品交期: 2-10個工作天內
價格
代謝性疾病用藥的全球市場(∼2021年):COVID-19影響與2030年前的復甦 Metabolic Disorders Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030
出版日期: 按訂單生產內容資訊: 英文 300 Pages
簡介

本報告提供全球代謝性疾病用藥市場的相關調查,提供市場規模和預測,佔有率,趨勢和策略,其他的市場與比較,成長及阻礙因素,類型·流通管道·給藥途徑·醫藥品分類·購買方法·各區各國的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 摘要整理

第2章 報告結構

第3章 市場特性

  • 市場定義
  • 主要的市場區隔

第4章 市場產品分析

  • 主要的產品/服務
  • 主要的功能與差異化要素
  • 開發產品

第5章 市場供應鏈

  • 供應鏈
  • 流通
  • 終端用戶

第6章 市場客戶資訊

  • 客戶的偏好
  • 最終用途的市場規模與成長

第7章 市場趨勢與策略

第8章 COVID-19的影響

第9章 市場規模與成長

  • 市場規模
  • 市場銷售額實際成果
    • 市場成長要素
    • 阻礙市場要素
  • 市場銷售額預測

第10章 市場地區分析

  • 全球市場:各區域銷售額(2020)
  • 全球市場:實際成果及預測(各地區)(2015-2020,2020-2025F,2030F)
  • 全球市場:成長及市場佔有率比較(各地區)

第11章 市場區隔

  • 全球市場及預測:各類型(2015-2020,2020-2025F,2030F)
  • 抗糖尿病藥物
  • 抗甲狀腺藥
  • 其他(副甲狀腺機能亢進症,下垂體功能降低症,腎上腺功能降低症)
  • 全球市場及預測:各流通管道(2015-2020,2020-2025F,2030F)
  • 醫院藥局
  • 零售藥局/藥妝店
  • 其他
  • 全球市場及預測:各給藥途徑(2015-2020,2020-2025F,2030F)
  • 口服
  • 非口服
  • 其他
  • 全球市場及預測:各醫藥品分類(2015-2020,2020-2025F,2030F)
  • 品牌藥
  • 學名藥
  • 全球市場及預測:各購買方法(2015-2020,2020-2025F,2030F)
  • 處方箋藥
  • 商店藥

第12章 市場指標

  • 全球市場規模,GDP的比例(2015-2025)
  • 每人的世界平均市場支出(2015-2025)

第13章 亞太地區市場

第14章 西歐市場

第15章 東歐市場

第16章 北美市場

第17章 南美市場

第18章 中東市場

第19章 非洲市場

第20章 市場競爭情形

  • 市場競爭概要
  • 市場佔有率
  • 企業簡介
    • Sanofi S.A
    • Novo Nordisk A/S
    • AstraZeneca Plc
    • Johnson & Johnson
    • Merck & Co

第21章 市場上主要合併和收購

第22章 市場背景:醫藥品市場

  • 市場特徵
  • 各分類市場銷售額成長率:實際成果·預測(2015-2020,2020-2025F,2030F)
  • 各地區:市場銷售額(2020)
  • 各地區:市場實際成果·預測(2015-2020,2020-2025F,2030F)
  • 各類型:市場銷售額(2015-2020,2020-2025F,2030F)

第23章 建議

  • 2025年的市場:成長國
  • 2025年的市場:成長市場區隔
  • 2025年的市場:成長策略

第24章 附錄

第25章 著作權和免責聲明

目錄

“Metabolic Disorders Drugs Global Market Report 2021: COVID 19 Impact and Recovery to 2030 ” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global metabolic disorders drugs market as it emerges from the Covid 19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the metabolic disorders drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Metabolic Disorders Drugs market global report from the Business Research Company ” answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider metabolic disorders drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The metabolic disorders drugs market section of the report gives context. It compares the metabolic disorders drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, metabolic disorders drugs indicators comparison.

Scope

Markets Covered: 1) By Type: Anti Diabetics drugs; Anti-Thyroid Drugs; Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Sanofi S.A; Novo Nordisk A/S; AstraZeneca Plc; Johnson & Johnson; Merck & Co

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, metabolic disorders drugs indicators comparison.

Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Metabolic Disorders Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Metabolic Disorders Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Metabolic Disorders Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Metabolic Disorders Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Metabolic Disorders Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Metabolic Disorders Drugs

9. Metabolic Disorders Drugs Market Size And Growth

  • 9.1. Market Size
  • 9.2. Historic Market Growth, Value ($ Billion)
    • 9.2.1. Drivers Of The Market
    • 9.2.2. Restraints On The Market
  • 9.3. Forecast Market Growth, Value ($ Billion)
    • 9.3.1. Drivers Of The Market
    • 9.3.2. Restraints On The Market

10. Metabolic Disorders Drugs Market Regional Analysis

  • 10.1. Global Metabolic Disorders Drugs Market, 2020, By Region, Value ($ Billion)
  • 10.2. Global Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • 10.3. Global Metabolic Disorders Drugs Market, Growth And Market Share Comparison, By Region

11. Metabolic Disorders Drugs Market Segmentation

  • 11.1. Global Metabolic Disorders Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Anti Diabetics drugs
  • Anti-Thyroid Drugs
  • Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
  • 11.2. Global Metabolic Disorders Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
  • 11.3. Global Metabolic Disorders Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
  • 11.4. Global Metabolic Disorders Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 11.5. Global Metabolic Disorders Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs

12. Metabolic Disorders Drugs Market Metrics

  • 12.1. Metabolic Disorders Drugs Market Size, Percentage Of GDP, 2015-2025, Global
  • 12.2. Per Capita Average Metabolic Disorders Drugs Market Expenditure, 2015-2025, Global

13. Asia-Pacific Metabolic Disorders Drugs Market

  • 13.1. Asia-Pacific Metabolic Disorders Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. Asia-Pacific, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • 13.3. Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Asia-Pacific, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Asia-Pacific, Metabolic Disorders Drugs Market Metrics
    • 13.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Asia-Pacific Countries
  • 13.6. Asia-Pacific Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • 13.7. Asia-Pacific Metabolic Disorders Drugs Market: Country Analysis
    • 13.7.1. China Metabolic Disorders Drugs Market
      • 13.7.1.1. China Metabolic Disorders Drugs Market Overview
      • 13.7.1.2. China Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 13.7.1.3. China Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.2. Australia Metabolic Disorders Drugs Market
      • 13.7.2.1. Australia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 13.7.2.2. Australia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.3. Hong Kong Metabolic Disorders Drugs Market
      • 13.7.3.1. Hong Kong Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.4. India Metabolic Disorders Drugs Market
      • 13.7.4.1. India Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 13.7.4.2. India Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.5. Indonesia Metabolic Disorders Drugs Market
      • 13.7.5.1. Indonesia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. Indonesia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.6. Japan Metabolic Disorders Drugs Market
      • 13.7.6.1. Japan Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Japan Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.7. Malaysia Metabolic Disorders Drugs Market
      • 13.7.7.1. Malaysia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.8. New Zealand Metabolic Disorders Drugs Market
      • 13.7.8.1. New Zealand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.9. Philippines Metabolic Disorders Drugs Market
      • 13.7.9.1. Philippines Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.10. Singapore Metabolic Disorders Drugs Market
      • 13.7.10.1. Singapore Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.11. South Korea Metabolic Disorders Drugs Market
      • 13.7.11.1. South Korea Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 13.7.11.2. South Korea Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.12. Thailand Metabolic Disorders Drugs Market
      • 13.7.12.1. Thailand Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 13.7.13. Vietnam Metabolic Disorders Drugs Market
      • 13.7.13.1. Vietnam Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

14. Western Europe Metabolic Disorders Drugs Market

  • 14.1. Western Europe Metabolic Disorders Drugs Market Overview
  • 14.2. Western Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • 14.3. Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Western Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Western Europe, Metabolic Disorders Drugs Market Metrics
    • 14.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Western Europe Countries
  • 14.6. Western Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • 14.7. Western Europe Metabolic Disorders Drugs Market: Country Analysis
    • 14.7.1. Austria Metabolic Disorders Drugs Market
      • 14.7.1.1. Austria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.2. Belgium Metabolic Disorders Drugs Market
      • 14.7.2.1. Belgium Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.3. Denmark Metabolic Disorders Drugs Market
      • 14.7.3.1. Denmark Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.4. Finland Metabolic Disorders Drugs Market
      • 14.7.4.1. Finland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.5. France Metabolic Disorders Drugs Market
      • 14.7.5.1. France Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 14.7.5.2. France Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.6. Germany Metabolic Disorders Drugs Market
      • 14.7.6.1. Germany Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 14.7.6.2. Germany Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.7. Ireland Metabolic Disorders Drugs Market
      • 14.7.7.1. Ireland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.8. Italy Metabolic Disorders Drugs Market
      • 14.7.8.1. Italy Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.9. Netherlands Metabolic Disorders Drugs Market
      • 14.7.9.1. Netherlands Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.10. Norway Metabolic Disorders Drugs Market
      • 14.7.10.1. Norway Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.11. Portugal Metabolic Disorders Drugs Market
      • 14.7.11.1. Portugal Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.12. Spain Metabolic Disorders Drugs Market
      • 14.7.12.1. Spain Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.13. Sweden Metabolic Disorders Drugs Market
      • 14.7.13.1. Sweden Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.14. Switzerland Metabolic Disorders Drugs Market
      • 14.7.14.1. Switzerland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 14.7.15. UK Metabolic Disorders Drugs Market
      • 14.7.15.1. UK Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 14.7.15.2. UK Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

15. Eastern Europe Metabolic Disorders Drugs Market

  • 15.1. Eastern Europe Metabolic Disorders Drugs Market Overview
  • 15.2. Eastern Europe, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • 15.3. Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • 15.4. Eastern Europe, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. Eastern Europe, Metabolic Disorders Drugs Market Metrics
    • 15.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Eastern Europe Countries
  • 15.6. Eastern Europe Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • 15.7. Eastern Europe Metabolic Disorders Drugs Market: Country Analysis
    • 15.7.1. Czech Republic Metabolic Disorders Drugs Market,
      • 15.7.1.1. Czech Republic Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 15.7.2. Poland Metabolic Disorders Drugs Market
      • 15.7.2.1. Poland Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 15.7.3. Romania Metabolic Disorders Drugs Market
      • 15.7.3.1. Romania Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 15.7.4. Russia Metabolic Disorders Drugs Market
      • 15.7.4.1. Russia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 15.7.4.2. Russia Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

16. North America Metabolic Disorders Drugs Market

  • 16.1. North America Metabolic Disorders Drugs Market Overview
  • 16.2. North America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • 16.3. North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • 16.4. North America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. North America, Metabolic Disorders Drugs Market Metrics
    • 16.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, North America Countries
  • 16.6. North America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • 16.7. North America Metabolic Disorders Drugs Market: Country Analysis
    • 16.7.1. Canada Metabolic Disorders Drugs Market
      • 16.7.1.1. Canada Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 16.7.2. Mexico Metabolic Disorders Drugs Market
      • 16.7.2.1. Mexico Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 16.7.3. USA Metabolic Disorders Drugs Market
      • 16.7.3.1. USA Metabolic Disorders Drugs Market Overview
      • 16.7.3.2. USA Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 16.7.3.3. USA Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

17. South America Metabolic Disorders Drugs Market

  • 17.1. South America Metabolic Disorders Drugs Market Overview
  • 17.2. South America, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • 17.3. South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • 17.4. South America, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. South America, Metabolic Disorders Drugs Market Metrics
    • 17.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, South America Countries
  • 17.6. South America Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • 17.7. South America Metabolic Disorders Drugs Market: Country Analysis
    • 17.7.1. Argentina Metabolic Disorders Drugs Market
      • 17.7.1.1. Argentina Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 17.7.2. Brazil Metabolic Disorders Drugs Market
      • 17.7.1.1. Brazil Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
      • 17.7.2.2. Brazil Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 17.7.3. Chile Metabolic Disorders Drugs Market
      • 17.7.3.1. Chile Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 17.7.4. Colombia Metabolic Disorders Drugs Market
      • 17.7.4.1. Colombia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 17.7.5. Peru Metabolic Disorders Drugs Market
      • 17.7.5.1. Peru Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 17.7.6. Venezuela Metabolic Disorders Drugs Market
      • 17.7.6.1. Venezuela Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

18. Middle East Metabolic Disorders Drugs Market

  • 18.1. Middle East Metabolic Disorders Drugs Market Overview
  • 18.2. Middle East, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • 18.3. Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Middle East, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Middle East, Metabolic Disorders Drugs Market Metrics
    • 18.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Middle East Countries
  • 18.6. Middle East Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • 18.7. Middle East Metabolic Disorders Drugs Market: Country Analysis
    • 18.7.1. Saudi Arabia Metabolic Disorders Drugs Market
      • 18.7.1.1. Saudi Arabia Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 18.7.2. Israel Metabolic Disorders Drugs Market
      • 18.7.2.1. Israel Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 18.7.3. Turkey Metabolic Disorders Drugs Market
      • 18.7.3.1. Turkey Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 18.7.4. UAE Metabolic Disorders Drugs Market
      • 18.7.4.1. UAE Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

19. Africa Metabolic Disorders Drugs Market

  • 19.1. Africa Metabolic Disorders Drugs Market Overview
  • 19.2. Africa, Metabolic Disorders Drugs Market, 2020, By Country, Value ($ Billion)
  • 19.3. Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Country
  • 19.4. Africa, Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth And Market Share Comparison, By Country
  • 19.5. Africa, Metabolic Disorders Drugs Market Metrics
    • 19.5.1. Per Capita Average Metabolic Disorders Drugs Expenditure, 2015-2025, Africa Countries
  • 19.6. Africa Metabolic Disorders Drugs Market, Segmentation By Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
  • 19.7. Africa Metabolic Disorders Drugs Market: Country Analysis
    • 19.7.1. Egypt Metabolic Disorders Drugs Market
      • 19.7.1.1. Egypt Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 19.7.2. Nigeria Metabolic Disorders Drugs Market
      • 19.7.2.1. Nigeria Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
    • 19.7.3. South Africa Metabolic Disorders Drugs Market
      • 19.7.3.1. South Africa Metabolic Disorders Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

20. Metabolic Disorders Drugs Market Competitive Landscape

  • 20.1. Competitive Market Overview
  • 20.2. Market Shares
  • 20.3. Company Profiles
    • 20.3.1. Sanofi S.A
      • 20.3.1.1. Company Overview
      • 20.3.1.2. Products And Services
      • 20.3.1.3. Strategy
      • 20.3.1.4. Financial Performance
    • 20.3.2. Novo Nordisk A/S
      • 20.3.2.1. Company Overview
      • 20.3.2.2. Products And Services
      • 20.3.2.3. Strategy
      • 20.3.2.4. Financial Performance
    • 20.3.3. AstraZeneca Plc
      • 20.3.3.1. Company Overview
      • 20.3.3.2. Products And Services
      • 20.3.3.3. Strategy
      • 20.3.3.4. Financial Performance
    • 20.3.4. Johnson & Johnson
      • 20.3.4.1. Company Overview
      • 20.3.4.2. Products And Services
      • 20.3.4.3. Strategy
      • 20.3.4.4. Financial Performance
    • 20.3.5. Merck & Co
      • 20.3.5.1. Company Overview
      • 20.3.5.2. Products And Services
      • 20.3.5.3. Strategy
      • 20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market

22. Market Background: Pharmaceutical Drugs Market

  • 22.1. Pharmaceutical Drugs Market Characteristics
  • 22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 22.3. Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
  • 22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic And Forecast, By Region
  • 22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation By Type, Value ($ Billion)

23. Recommendations

  • 23.1. Global Metabolic Disorders Drugs Market In 2025- Growth Countries
  • 23.2. Global Metabolic Disorders Drugs Market In 2025- Growth Segments
  • 23.3. Global Metabolic Disorders Drugs Market In 2025- Growth Strategies

24. Appendix

  • 24.1. NAICS Definitions Of Industry Covered In This Report
  • 24.2. Abbreviations
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company

25. Copyright And Disclaimer